Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Dividends Paid - CommonFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ardent Health (ARDT) Cash from Financing Activities (2023 - 2025)

Historic Cash from Financing Activities for Ardent Health (ARDT) over the last 3 years, with Q3 2025 value amounting to -$26.9 million.

  • Ardent Health's Cash from Financing Activities fell 11468.23% to -$26.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$86.9 million, marking a year-over-year decrease of 41910.99%. This contributed to the annual value of $24.6 million for FY2024, which is 12409.69% up from last year.
  • Ardent Health's Cash from Financing Activities amounted to -$26.9 million in Q3 2025, which was down 11468.23% from -$25.7 million recorded in Q2 2025.
  • In the past 5 years, Ardent Health's Cash from Financing Activities ranged from a high of $183.4 million in Q3 2024 and a low of -$119.8 million during Q2 2024
  • Moreover, its 3-year median value for Cash from Financing Activities was -$20.5 million (2024), whereas its average is -$9.3 million.
  • In the last 5 years, Ardent Health's Cash from Financing Activities skyrocketed by 86712.82% in 2024 and then plummeted by 11468.23% in 2025.
  • Over the past 3 years, Ardent Health's Cash from Financing Activities (Quarter) stood at -$17.9 million in 2023, then decreased by 14.48% to -$20.5 million in 2024, then plummeted by 31.47% to -$26.9 million in 2025.
  • Its last three reported values are -$26.9 million in Q3 2025, -$25.7 million for Q2 2025, and -$13.8 million during Q1 2025.